Adjuvant tislelizumab plus TACE in resected high-risk hepatocellular carcinoma (ATTACK): Preliminary analysis of a prospective cohort study

被引：0
作者：
Liu, J. [1 ]
Zeng, D. [2 ]
Cheng, Y. [1 ]
Li, Y. [1 ]
Zhang, M. [1 ]
Song, S. [2 ]
Huang, Y. [1 ]
机构：
[1] Shanghai Publ Hlth Clin Ctr, Hepatobiliary Surg Dept, Shanghai, Peoples R China
[2] Shanghai Publ Hlth Clin Ctr, Dept Pathol, Shanghai, Peoples R China
来源：
ANNALS OF ONCOLOGY | 2024年 / 35卷
关键词：
D O I：
10.1016/j.annonc.2024.10.247
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
227P
引用
收藏
页码：S1490 / S1490
页数：1
相关论文
共 50 条
[41]   Adjuvant HAIC combined with anlotinib and TQB2450 for resected high risk hepatocellular carcinoma- [J].
Zhang, Ning ;
Zhang, Yongfa ;
Yu, Bingran ;
Wang, Yixiu ;
Wang, Miao ;
Pan, Qi ;
Mao, Anrong ;
Zhu, Weiping ;
Zhao, Yiming ;
Zhang, Ti ;
Wang, Lu .
INNOVATION, 2025, 6 (07)
[42]   Treatment Duration of Adjuvant Immune Checkpoint Inhibitors in Hepatocellular Carcinoma Patients at High Risk of Recurrence after Resection: A Prospective, Multicentric Cohort Study [J].
Su, Jia-Yong ;
Liu, Shao-Ping ;
Xu, Xiao-Ling ;
Ou, Jun-Jie ;
Ye, Po-Hua ;
Zhao, Bin-Tong ;
Chen, Jia-Song ;
Luo, Qiu-Mei ;
Liu, Jin-Rong ;
Tang, Fei-Min ;
Li, Jian-Rong ;
Yang, Da-Long ;
Deng, Zhu-Jian ;
Pan, Li-Xin ;
Li, Yao-Jie ;
Li, Le ;
Qin, Zhen-Ming ;
Liang, Xiu-Mei ;
Ma, Yi-Li ;
Ma, Liang ;
Zhong, Jian-Hong .
LIVER CANCER, 2024,
[43]   Combination of TACE and FOLFOX4 in the treatment of unresectable advanced hepatocellular carcinoma: a prospective cohort study [J].
Jingyan Wang ;
Linzhi Zhang ;
Xiaoming Peng ;
Yun Zhao ;
Lin Zhou .
OncologyandTranslationalMedicine, 2020, 6 (05) :208-216
[44]   Challenges in Adjuvant Immunotherapy after Resection or Ablation for Hepatocellular Carcinoma at High-Risk of Recurrence [J].
Kudo, Masatoshi .
LIVER CANCER, 2024, 13 (06) :573-578
[45]   Transarterial chemoembolization (TACE) plus lenvatinib versus TACE plus sorafenib for hepatocellular carcinoma (HCC) with portal vein tumour thrombus (PVTT): A prospective randomized study [J].
Ding, X. ;
Sun, W. ;
Chen, J. ;
Li, W. ;
Shen, Y. ;
Guo, X. ;
Teng, Y. ;
Liu, X. ;
Li, W. .
ANNALS OF ONCOLOGY, 2020, 31 :S1306-S1306
[46]   UTILITY OF THE GAAD ALGORITHM IN HEPATOCELLULAR CARCINOMA SURVEILLANCE AMONG A HIGH-RISK COHORT [J].
Larrea, Emily ;
Gemma Serrano, Maria ;
Marin, Eva ;
Poza, Joaquin ;
Abadia, Marta ;
Ruiz, Gloria ;
Gonzalez, Irene ;
Amor, Carmen ;
Amiama, Clara ;
Gayoso, Rafael ;
Torrijos, Paula ;
Cerpa, Alberto ;
Fernandez-Martos, Ruben ;
Zarauza, Yolanda ;
Mayor, Patricia ;
Cuadros, Marta ;
Sanchez-Azofra, Maria ;
Erdozain, Jose ;
Romero, Miriam ;
Castillo, Pilar ;
Garcia-Sanchez, Araceli ;
Garcia-Samaniego, Francisco ;
Cano, Susana ;
Ucle, Veronica ;
Alvarez, Sonia ;
Serres, Mariana ;
Sanz de Pedro, Maria ;
Buno, Antonio ;
Olveira, Antonio .
HEPATOLOGY, 2024, 80
[47]   Comparison of adjuvant treatment regimens for high-risk hepatocellular carcinoma: a Bayesian network meta analysis and systematic review [J].
Li, Jiahao ;
Liu, Yingnan ;
Qiu, Yuqi ;
Qu, Chao ;
Li, Jiarui .
FRONTIERS IN IMMUNOLOGY, 2024, 15
[48]   Multimodality Screening of High-Risk Women: A Prospective Cohort Study [J].
Weinstein, Susan P. ;
Localio, A. Russell ;
Conant, Emily F. ;
Rosen, Mark ;
Thomas, Kathleen M. ;
Schnall, Mitchell D. .
JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (36) :6124-6128
[49]   A retrospective analysis of tislelizumab and GP regimen neoadjuvant therapy followed by concurrent chemoradiotherapy plus nimotuzumab in patients with high-risk nasopharyngeal carcinoma [J].
Zhang, Qinhua ;
Lai, Mingfen ;
Li, Fangming ;
Chen, Jiarong ;
Chang, Mingzhang ;
Yang, Peixin ;
Chen, Guojian .
JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
[50]   High-risk Surgically Resected Renal Cell Carcinoma: Is There a Role for Adjuvant VEGF-TKI Inhibitors? [J].
Fallara, Giuseppe ;
Bandini, Marco ;
Larcher, Alessandro ;
Pederzoli, Filippo ;
Karakiewicz, Pierre ;
Tian, Zhe ;
Briganti, Alberto ;
Necchi, Andrea ;
Salonia, Andrea ;
Bertini, Roberto ;
Montorsi, Francesco ;
Bex, Axel ;
Capitanio, Umberto .
CURRENT PROBLEMS IN CANCER, 2021, 45 (06)
12345